FAQ: Nutriband Inc.'s AVERSA™ Abuse-Deterrent Transdermal Technology

What is Nutriband Inc. and what is their main innovation?

Nutriband Inc. (NASDAQ: NTRB) is a company that sustains itself through multiple revenue-generating subsidiaries, with its core innovation being the AVERSA™ platform - a proprietary abuse-deterrent transdermal technology designed to prevent misuse of drugs with high abuse potential.

What is the AVERSA™ technology and how does it work?

AVERSA™ is an abuse-deterrent transdermal technology that integrates aversive agents into transdermal patches to prevent misuse, abuse, and accidental exposure of drugs, particularly opioids. It transforms traditional transdermal patches into safer tools for patients requiring powerful pain relief.

Why is this technology significant in the current healthcare landscape?

This technology addresses the urgent need for safer drug delivery methods highlighted by the ongoing opioid crisis. It aims to reduce the risks that have fueled the national opioid epidemic while providing effective pain relief for patients who need it.

What are the projected financial impacts of AVERSA™ fentanyl?

AVERSA™ fentanyl is projected to achieve peak annual sales of $200 million upon FDA approval, with upside potential exceeding $800 million, representing significant revenue potential for the company.

When and where was this technology recently showcased?

The technology was showcased at the August 2025 Emerging Growth Conference by Nutriband founder and president Serguei Melnik, who detailed the company’s lead product and growth trajectory since its founding in 2016.

How is Nutriband structured differently from other biotechnology companies?

Unlike many biotechnology companies that rely solely on investor capital while burning through funds, Nutriband sustains itself through multiple revenue-generating subsidiaries, providing a more sustainable business model.

Where can investors find more information about Nutriband Inc.?

The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB, and more details about the conference presentation can be found at https://ibn.fm/1qrav.

What types of drugs is AVERSA™ technology designed to protect?

The technology is specifically designed for drugs with high abuse potential, particularly opioids like fentanyl, to prevent misuse, abuse, and accidental exposure while maintaining therapeutic effectiveness for legitimate patients.